about
Regulation of several androgen-induced genes through the repression of the miR-99a/let-7c/miR-125b-2 miRNA cluster in prostate cancer cells.Candidate pathways and genes for prostate cancer: a meta-analysis of gene expression data.Shikonin inhibits the growth of human prostate cancer cells via modulation of the androgen receptor.Tissue slice grafts: an in vivo model of human prostate androgen signalingCharacterization of tumor differentiation factor (TDF) and its receptor (TDF-R).A Tale of Two Signals: AR and WNT in Development and Tumorigenesis of Prostate and Mammary Gland.Oncogenic activation of ERG: A predominant mechanism in prostate cancer.Genome-wide analysis of androgen receptor binding sites in prostate cancer cells.Effect of curcumin on the interaction between androgen receptor and Wnt/β-catenin in LNCaP xenografts.Proteomic analysis of microvesicles released by the human prostate cancer cell line PC-3SH003 induces apoptosis of DU145 prostate cancer cells by inhibiting ERK-involved pathwayRNA editing of androgen receptor gene transcripts in prostate cancer cells.Transcriptional repression and inhibition of nuclear translocation of androgen receptor by diallyl trisulfide in human prostate cancer cells.D,L-Sulforaphane causes transcriptional repression of androgen receptor in human prostate cancer cells.The interplay of AMP-activated protein kinase and androgen receptor in prostate cancer cells.Association of serum calcium with serum sex steroid hormones in men in NHANES III.Proteomics approach to identify novel metastatic bone markers from the secretome of PC-3 prostate cancer cells.KLK5 gene expression is severely upregulated in androgen-independent prostate cancer cells after treatment with the chemotherapeutic agents docetaxel and mitoxantrone.Induction of the SUMO-specific protease 1 transcription by the androgen receptor in prostate cancer cells.Estrogen receptors alpha and beta in male and female gerbil prostates.A feedback loop between the androgen receptor and a NEDD4-binding protein, PMEPA1, in prostate cancer cells.ERG immunohistochemistry is not predictive for PSA recurrence, local recurrence or overall survival after radical prostatectomy for prostate cancer.The Genomics of Prostate Cancer: emerging understanding with technologic advances.Association of ERG and TMPRSS2-ERG with grade, stage, and prognosis of prostate cancer is dependent on their expression levels.Serum calcium and incident and fatal prostate cancer in the Swedish AMORIS study
P2860
Q30410739-17DC865E-2ED2-46B3-BD45-7994EB9357B7Q33490254-35B35B47-F7B5-4EB2-8BC6-3A5A09FFDF5EQ33637037-CCB3B9E3-744C-460E-BEFE-8EE3E965F0CCQ33947237-D0F7A8B4-832F-4898-8873-989FE8FD5BB3Q34449941-0C6E14D4-966F-4EE2-B4A3-C47CC8B08B8EQ34550256-4770E4DB-0FC8-4DFC-B8DB-23ED64CEEBE5Q35685920-F129A9A5-EFA4-448F-A840-05EBCBB74C5DQ35758864-93589CCB-3B79-4C1F-9405-111FD3EEF4F5Q36048716-F1143763-7B7F-4DD0-9679-4C3846D7FF50Q36089842-8E30CC88-B9B5-4904-99E0-06C263DC20D3Q36215285-93873613-A79D-4E1D-B445-3AF94DEBA5C2Q37142544-567251D2-B6DE-4D9B-AA13-937B19DD948AQ37285917-F57ED09A-BDE0-405B-A9CF-5F1B37DAF91FQ37426675-C52106F8-D651-4ADD-8DC5-0782E1E42B22Q37626493-F85FDC19-C981-4C37-A70E-A1E067D77737Q37733635-3D8B557C-4302-413A-A05D-308DF12F9D0FQ38699865-018A6114-ED14-4C9C-AC90-61C50C654515Q39744334-A537247B-A40E-4D25-8789-B8C8022B29EEQ40068850-CAEBFA01-0F30-410E-B7CC-56177E0C124AQ42516532-67265F67-65CD-453F-9A72-1D2AABE7CB79Q43252751-EB658249-C8AC-4119-8575-E6B91B2E70B2Q43684650-BEAE5E15-C40B-4FD3-822A-9AC269F4B126Q48317607-D11520AA-B40D-4DAF-BCD3-C1D2CDFB3631Q53519887-EDCB79B2-C466-4D77-A880-3B9B534DAB4BQ58813375-E6B17C30-1128-4C5F-A6CD-C047FE6A0E5F
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Androgen receptor and prostate cancer.
@ast
Androgen receptor and prostate cancer.
@en
type
label
Androgen receptor and prostate cancer.
@ast
Androgen receptor and prostate cancer.
@en
prefLabel
Androgen receptor and prostate cancer.
@ast
Androgen receptor and prostate cancer.
@en
P2093
P2860
P356
P1476
Androgen receptor and prostate cancer.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.PCAN.4500936
P577
2007-02-13T00:00:00Z